15th Annual NATA Symposium Scientific Program

Scientific Program

Thursday, April 10, 2014

MORNING

8:45-9:00 Welcome Address
Dafydd Thomas, Swansea, Wales, UK
 

BLOOD TRANSFUSION SERVICES IN 2014

Rainer Moog, Berlin, Germany
Matilde Santos, Lisbon, Portugal



9:00-9:20 Update on the Safety of Blood Products
Lawrence Tim Goodnough, Stanford, CA, USA

9:20-9:40 Informed Consent for Transfusion
Richard Daniel, London, UK

9:40-10:00 Trends in Blood Utilization
Lawrence Tim Goodnough, Stanford, CA, USA

10:00-10:30 Questions and Answers


10:30-11:00 Break


THE SAFETY OF BLOOD AND ALTERNATIVES

Jens Meier, Tübingen, Germany
José Eduardo Torres de Eckenroth Guimarães, Porto, Portugal



11:00-11:20 Age of Blood: Does It Matter?
Jeffrey L. Carson, New Brunswick, NJ, USA

11:20-11:40 The Safety of Intravenous Iron and Erythropoiesis-Stimulating Agents
Iain C. Macdougall, London, UK

11:40-12:00 The Safety of Antifibrinolytics and Recombinant Activated Factor VII
Beverley J. Hunt, London, UK

12:00-12:30 Questions and Answers


WORKSHOP: CELL SALVAGE FOR THE INEXPERIENCED
—AN OVERVIEW OF THE AVAILABLE TECHNOLOGIES

Dafydd Thomas, Swansea, Wales, UK
Jonathan H. Waters, Pittsburg, PA, USA


11:00-12:30 (Maximum 30 participants)


WORKSHOP: PERIOPERATIVE AND EMERGENCY MANAGEMENT OF ORAL ANTICOAGULANTS

Charles-Marc Samama, Paris, France
Marcel Levi, Amsterdam, The Netherlands


11:00-12:30 (Maximum 30 participants)


LUNCHTIME INDUSTRY-SPONSORED SATELLITE SYMPOSIUM

Importance of Fat Elimination in Intraoperative Blood Salvage


12:45-13:15 Positive Effects of Intraoperative Blood Salvage and Fat Elimination
during Cardiac Surgery

George N. Djaiani, Toronto, ON, Canada

13:15-13:45 Continuous Autotransfusion Allows for Fat Elimination
during Orthopedic Surgery

Michael Booke, Bad Soden am Taunus, Germany

13:45-14:15 Questions and Answers


Thursday, April 10, 2014

AFTERNOON

CELL SALVAGE: WHEN AND HOW?

Manuel Muñoz, Málaga, Spain
Lucindo Ormonde, Lisbon, Portugal


14:30-14:50 Basic Principles and Safety of Cell Salvage
Dafydd Thomas, Swansea, Wales, UK

14:50-15:10 Cell Salvage in Cancer Surgery
Jonathan H. Waters, Pittsburgh, PA, USA

15:10-15:30 Washing of Banked Red Blood Cells with Cell Salvage Devices
Ernil Hansen, Regensburg, Germany

15:30-16:00 Questions and Answers


WORKSHOP: PATIENT BLOOD MANAGEMENT
—THE BASICS

Elvira Bisbe, Barcelona, Spain
Oliver Habler, Frankfurt, Germany

 
14:30-16:00 (Maximum 30 participants)


WORKSHOP: MANAGEMENT OF MASSIVE BLEEDING
—MEET THE EXPERTS

Sibylle A. Kozek-Langenecker, Vienna, Austria
Rolf Rossaint, Aachen, Germany

 
14:30-16:00 (Maximum 30 participants)


16:00-16:30 Break


BEST POSTERS’ PRESENTATION

Jean-François Hardy, Montreal, QC, Canada
Elvira Bisbe, Barcelona, Spain



16:30-16:45 Factors Influencing the Delay in Traumatic Coagulopathy Occurrence Following Traumatic Brain Injury
Frédéric Dallaire, Montreal, QC, Canada

16:45-17:00 Preoperative Anemia and Its Impact on Clinical Outcomes in Patients Undergoing Non-Cardiac Surgery: An Audit at Centro Hospitalar Porto
Diogo Sobreira Fernandes, Porto, Portugal

17:00-17:15 Cell Salvage in Hip and Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials
Cynthia So-Osman, Leiden, The Netherlands

17:15-17:30 Tight Control of Coagulopathy Decreases Overall Transfusion and Results in Improved Patient Outcomes
Maria Armstrong, London, UK


17:45-18:30 NATA General Assembly


Friday, April 11, 2014

MORNING

BREAKING NEWS

Dafydd Thomas, Swansea, Wales, UK
Hans Gombotz, Linz, Austria

 
9:00-9:20 Transfusion Thresholds for Patients with Coronary Artery Disease
Jeffrey L. Carson, New Brunswick, NJ, USA

9:20-9:40 Targeted Action for Curing Trauma Induced Coagulopathy (TACTIC)
—A 5-year Research Program to Investigate Abnormal Bleeding in Trauma Patients

Pär I. Johansson, Copenhagen, Denmark

9:40-10:00 Perioperative Administration of Intravenous Iron Isomaltoside 1000 (Monofer®) in Non-anemic Patients Undergoing Cardiac Surgery
Daniel Steinbrüchel, Copenhagen, Denmark

10:00-10:30 Questions and Answers

10:30-11:00 Break


THE CHALLENGES POSED BY NEW ORAL ANTICOAGULANTS

Charles-Marc Samama, Paris, France
Marcel Levi, Amsterdam, The Netherlands

 
11:00-11:20 Can We Monitor New Oral Anticoagulants?
Michael Spannagl, Munich, Germany

11:20-11:40 The Perioperative Management of New Oral Anticoagulants in Elective Surgery
Charles-Marc Samama, Paris, France

11:40-12:00 Urgent Reversal of New Oral Anticoagulants
Marcel Levi, Amsterdam, The Netherlands

12:00-12:30 Questions and Answers


WORKSHOP: CELL SALVAGE FOR THE INEXPERIENCED
—AN OVERVIEW OF THE AVAILABLE TECHNOLOGIES

Dafydd Thomas, Swansea, Wales, UK
Jonathan H. Waters, Pittsburgh, PA, USA

 
11:00-12:30 (Maximum 30 participants)


WORKSHOP: MANAGEMENT OF MASSIVE BLEEDING
—MEET THE EXPERTS

Sibylle A. Kozek-Langenecker, Vienna, Austria
Rolf Rossaint, Aachen, Germany

 
11:00-12:30 (Maximum 30 participants)


LUNCHTIME INDUSTRY-SPONSORED LECTURES

 
12:45-13:05 Identifying Cardiac Surgery Patients at Risk of Major Transfusion: A Review of 1349 Patients Operated at the Montreal University Health Center
Jean-François Hardy, Montreal, QC, Canada

13:05-13:15 Questions and Answers

13:15-13:35 When Is Aprotinin an Essential Medication to Reduce Bleeding in Cardiac Surgery?
Jan van der Linden, Stockholm, Sweden

13:35-13:45 Questions and Answers

 

LUNCHTIME INDUSTRY-SPONSORED LECTURE

 
13:45-14:05 A New Approach to Transfusion Triggers in Elective Surgery
Giambattista Bertani, Milan, Italy

14:05-14:15 Questions and Answers


Friday, April 11, 2014

AFTERNOON

UNDERSTANDING AND MONITORING COAGULOPATHY IN CLINICAL PRACTICE

Pär I. Johansson, Copenhagen, Denmark
Luis Manuel Cunha Ribeiro, Porto, Portugal

 
14:30-14:50 Understanding and Monitoring Coagulopathy in Elective Surgery
Sibylle A. Kozek-Langenecker, Vienna, Austria

14:50-15:10 Understanding and Monitoring Coagulopathy in Trauma
Rolf Rossaint, Aachen, Germany

15:10-15:30 Understanding and Monitoring Coagulopathy in Obstetrics
Beverley J. Hunt, London, UK

15:30-16:00 Questions and Answers


WORKSHOP: PATIENT BLOOD MANAGEMENT
—THE BASICS

Hans Gombotz, Linz, Austria
Oliver Habler, Frankfurt, Germany

 
14:30-16:00 (Maximum 30 participants)


WORKSHOP: PERIOPERATIVE AND EMERGENCY MANAGEMENT OF ORAL ANTICOAGULANTS

Charles-Marc Samama, Paris, France
David Faraoni, Brussels, Belgium

 
14:30-16:00 (Maximum 30 participants)


16:00-16:30 Break


PRO/CON DEBATE:
SHOULD HYDROXYETHYL STARCHES BE ABANDONED?

Oliver Habler, Frankfurt, Germany
Ricardo Matos, Lisbon, Portugal


 
16:30-16:50 Yes, Hydroxyethyl Starches Should Be Abandoned
Nicolai Haase, Copenhagen, Denmark

16:50-17:10 No, Hydroxyethyl Starches Should Not Be Abandoned
Philippe Van der Linden, Brussels, Belgium

17:10-17:30 Discussion


17:30 Concluding Comments
Dafydd Thomas, Swansea, Wales, UK